# Safety and Tolerability of FMT Capsules in Healthy Volunteers

> **NCT05352269** · PHASE1 · UNKNOWN · sponsor: **Shenzhen Xbiome Biotech Co., Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Acute-graft-versus-host Disease

## Interventions

- **BIOLOGICAL:** XBI-302
- **BIOLOGICAL:** XBI-302 Placebo

## Key facts

- **NCT ID:** NCT05352269
- **Lead sponsor:** Shenzhen Xbiome Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-21
- **Primary completion:** 2022-08
- **Final completion:** 2022-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2022-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05352269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05352269, "Safety and Tolerability of FMT Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05352269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*